The effect of amlodipine and the combination of amlodipine and enalapril on the renin‐angiotensin‐aldosterone system in the dog
Authors:
- C. E. AtkinsCAC. E. Atkins
- W. P. RauschWRW. P. Rausch
- S. Y. GardnerSGS. Y. Gardner
- T. C. DefrancescoTDT. C. Defrancesco
- B. W. KeeneBKB. W. Keene
- J. F. LevineJLJ. F. Levine
- 17 August 2007
- journal article
- research article
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 30 (5) , 394-400
Abstract
Excessive aldosterone secretion is detrimental to the heart, vessels and kidneys, contributing to hypertension and the signs and progression of heart failure. Aldosterone secretion, abnormally elevated in heart failure and hypertension, can be blunted with angiotensin‐converting enzyme inhibitors. Amlodipine, used to treat hypertension and heart failure, was hypothesized to activate the renin‐angiotensin‐aldosterone system (RAAS). A study was conducted with six normal adult male beagle dogs. Each dog received amlodipine (0.57 mg/kg b.i.d.) for 6 days, followed by amlodipine (0.57 mg/kg b.i.d.) and enalapril (0.57 mg/kg b.i.d.) for 4 days. Blood pressure, heart rate, serum chemistries and urinary aldosterone excretion, as a measure of RAAS activation, were compared with baseline values. Blood pressure fell by approximately 7% with amlodipine (P = 0.05) and a further 7% with the combination of amlodipine and enalapril (P < 0.01). Blood urea nitrogen increased with the combination (P < 0.05) but only one dog became mildly azotemic. Renin‐angiotensin‐aldosterone system activation, based on 24 h urinary aldosterone excretion and by aldosterone:creatinine ratio was increased by approximately threefold (P < 0.05) with amlodipine administration. This effect was blunted by enalapril, such that aldosterone excretion was no longer different from that observed under control conditions, although values for 24‐h aldosterone excretion did not return to pretreament levels.Keywords
This publication has 36 references indexed in Scilit:
- Guidelines for the Identification, Evaluation, and Management of Systemic Hypertension in Dogs and CatsJournal of Veterinary Internal Medicine, 2007
- Furosemide Continuous Rate Infusion in the Horse: Evaluation of Enhanced Efficacy and Reduced Side EffectsJournal of Veterinary Internal Medicine, 2003
- Spontaneous Feline Hypertension: Clinical and Echocardiographic Abnormalities, and Survival RateJournal of Veterinary Internal Medicine, 2003
- Effect of Amlodipine on Echocardiographic Variables in Cats with Systemic HypertensionJournal of Veterinary Internal Medicine, 2001
- Ocular lesions associated with systemic hypertension in cats: 69 cases (1985–1998)Journal of the American Veterinary Medical Association, 2000
- Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1996
- Effectiveness of Spironolactone Added to an Angiotensin-Converting Enzyme Inhibitor and a Loop Diuretic for Severe Chronic Congestive Heart Failure (The Randomized Aldactone Evaluation Study [RALES])**See Appendix for full list of RALES investigators.The American Journal of Cardiology, 1996
- Role of aldosterone in the remnant kidney model in the rat.Journal of Clinical Investigation, 1996
- Acute pulmonary vasodilatory properties of amlodipine in humans with pulmonary hypertension.Heart, 1996
- Pharmacologic profile of amlodipineThe American Journal of Cardiology, 1989